Newsroom

Sera Prognostics Inc., The Pregnancy Company® announced certain commercial changes and plans to optimize its strategy and commercial structure to highly focus business activities on accelerating test adoption and revenue at significantly reduced operating costs.

Salt Lake City – May 10, 2023 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to…

Sera Prognostics Inc., today announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S., effective June 8, 2023. Zhenya Lindgardt, a member of the Company’s Board of Directors, will succeed Dr. Critchfield, as Interim CEO & President.

Sera Prognostics Inc., announced that it will report first quarter fiscal year 2023 financial results on Wednesday, May 10, 2023, after the close of the market.

SALT LAKE CITY, March 22, 2023 — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and…

Sera Prognostics, Inc., announced that it will report fourth quarter and full year 2022 financial results on Wednesday, March 22, 2023, after the close of the market.

Sera Prognostics Inc. announced that the company will present at the upcoming Cowen Health Care Conference March 6-8, 2023 in Boston and the Oppenheimer 33rd Annual Healthcare Conference held to be held virtually March 13-15, 2023.

PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay

Sera Prognostics and Fors Marsh are collaborating to provide Sera’s PreTRM® Test to employees at Fors Marsh as part of their maternity benefits, effective January 1, 2023.

Sera Prognostics Inc. announced the publication of results from a clinical utility and cost-effectiveness modeling study, ACCORDANT (Analyses aCross Congruent studies ReDucing Adverse pregNancy ouTcomes).